Skip to main content

Table 2 Baseline Clinical Characteristics

From: Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

 

Lesion length

< 20 mm

Lesion length

≥20 mm

P-values

Number of patients

190

136

 

Age, years

61.4 ± 11.1

62.5 ± 9.8

0.35

Male sex, N (%)

152 (80.0)

100 (73.5)

0.17

Hypertension, N (%)

146 (76.8)

104 (76.5)

0.94

Diabetes mellitus, N (%)

44 (23.2)

23 (16.9)

0.17

Hyperlipidemia, N (%)

152 (80.0)

102 (75.0)

0.28

History of smoking, N (%)

98 (51.6)

76 (55.9)

0.33

Renal insufficiency, N (%)

16 (8.4)

16 (11.8)

0.61

Body mass index, kg/m2

27.8 ± 4.5

27.6 ± 4.9

0.64

Family history, N (%)

65 (34.2)

61 (44.9)

0.14

Number of diseased vessels

2.2 ± 0.8

2.5 ± 0.7

< 0.001

Stable angina, N (%)

106 (55.8)

77 (56.6)

0.88

ACS, N (%)

84 (44.2)

59 (43.4)

0.88

  1. Data are presented as mean value±SD or percentage of patients. ACS: acute coronary syndrome